MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
about
In vitro comparative models for canine and human breast cancersCircadian disruption and breast cancer: an epigenetic link?ApoptomiRs of Breast Cancer: Basics to ClinicsmiR-183 inhibits invasion of gastric cancer by targeting Ezrin.miR-99a directly targets the mTOR signalling pathway in breast cancer side population cells.A ranking-based meta-analysis reveals let-7 family as a meta-signature for grade classification in breast cancerFood Deprivation Affects the miRNome in the Lactating Goat Mammary Gland.miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.Noncoding RNAs in breast cancer.A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growthmiRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer.PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.Emerging Role of MicroRNAs in mTOR Signaling.Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma.miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.MicroRNA-99a is a novel regulator of KDM6B-mediated osteogenic differentiation of BMSCs.The application of aptamer 5TR1 in triple negative breast cancer target therapy.Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells.Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.mTOR signaling-related MicroRNAs and Cancer involvement.Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells
P2860
Q26752714-01DB751E-BBC0-496E-B70B-4A9FB17575FFQ26798258-500400B2-9B33-491D-8289-3EB799341AAFQ28072414-54A245FE-0B12-4EAD-BF1E-C7C32C971B76Q34371214-9D99A0EC-3BC4-4679-8E8B-2FE083E1AD27Q35369612-AF222788-5F02-491F-9E6F-264391854727Q35610804-F0088CB0-1E98-4C0D-A97A-B241C8475EA8Q35810180-6485E188-1CA9-4767-BCF6-A5E4CCAE740BQ36544789-E4295F49-409F-4554-9DB9-8915C084995EQ36935047-9C4A7CF5-949F-46E7-ACB4-B0C60B0920A3Q37109741-DA694CAC-E08A-4EB0-B961-A921EED78579Q37297592-2E3027CD-78AD-48B5-B4DE-41B44DF57467Q37741239-E76FE032-5989-430E-926F-64B1A0D30FAFQ38336073-C1A03686-409A-4880-836E-41EEA5C4F24DQ38960051-56C9773F-C4ED-42C7-BB83-FD0F31085A09Q39151248-9514FCE4-61CE-4DF2-913D-136A51F768CCQ39464836-1988D591-3BFE-4EFC-9E13-16A5AB2B3940Q45992649-4DAEC692-5C3F-4E93-8DCC-2A630A4C4FB1Q48150873-233DA560-6194-467B-B5D9-A3ED63D14B62Q48187126-E9A2387E-2955-487B-9601-6CF1097DCEACQ48325270-45061178-CBF3-4BD2-AD43-83BD15FB8DB5Q49425667-E15BD230-1F50-41DF-B02E-25D1053A8AE7Q52334742-2967BEE9-E29F-483E-AA3C-8756AEC9B71FQ55069878-4E1947FD-FDA8-429D-AC8D-29EBA3AB5F2DQ58609457-6EFAA53D-7E16-4037-AC00-C190A8A8726C
P2860
MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MiR-99a antitumor activity in ...... targeting of mTOR expression.
@ast
MiR-99a antitumor activity in ...... targeting of mTOR expression.
@en
type
label
MiR-99a antitumor activity in ...... targeting of mTOR expression.
@ast
MiR-99a antitumor activity in ...... targeting of mTOR expression.
@en
prefLabel
MiR-99a antitumor activity in ...... targeting of mTOR expression.
@ast
MiR-99a antitumor activity in ...... targeting of mTOR expression.
@en
P2093
P2860
P1433
P1476
MiR-99a antitumor activity in ...... targeting of mTOR expression.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0092099
P407
P577
2014-03-17T00:00:00Z